Reporting quality and adherence of randomized controlled trials about statins and/or fibrates for diabetic retinopathy to the CONSORT checklist

Reporting quality of randomized controlled trials in otolaryngology: review of adherence to the CONSORT statement

(2018) Yu Qing Huang et al.   Journal of Otolaryngology-Head & Neck Surgery

Reporting quality of randomised controlled trial abstracts on age-related macular degeneration health care: a cross-sectional quantification of the adherence to CONSORT abstract reporting recommendations

(2018) Christine Baulig et al.   BMJ Open

A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network

(2016) Douglas G Altman et al.   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE

Statins and fibrates as the treatment of nonproliferative diabetic retinopathy in type 2 diabetes mellitus

(2016) Yevgeniya Ilyina et al.   Spektrum der Augenheilkunde

Four Proposals to Help Improve the Medical Research Literature

(2015) David Moher et al.   PLOS MEDICINE

Reducing waste from incomplete or unusable reports of biomedical research

(2014) Paul Glasziou et al.   LANCET

Effects of Fenofibric Acid on Diabetic Macular Edema: The MacuFen study

(2014) Pascale Massin et al.   OPHTHALMIC EPIDEMIOLOGY

The Effects of Medical Management on the Progression of Diabetic Retinopathy in Persons with Type 2 Diabetes

(2014) Emily Y. Chew et al.   OPHTHALMOLOGY

Consort 2010 statement: extension to cluster randomised trials

(2012) M. K. Campbell et al.   BMJ-British Medical Journal

Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Wirksamkeit und Sicherheit von Etofibrat bei Patienten mit nicht proliferativer diabetischer Retinopathie

(2009) K.-H. Emmerich et al.   KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE